Drug
Tranexamic Acid (IV)
Tranexamic Acid (IV) is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
40%
Ph phase_3
1
20%
Ph phase_2
1
20%
Ph not_applicable
1
20%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(1)
Other(1)
Detailed Status
Recruiting2
Completed1
Not yet recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)
Trials by Status
completed120%
not_yet_recruiting120%
unknown120%
recruiting240%
Recent Activity
2 active trials
Showing 5 of 5
recruitingnot_applicable
Precision Use of TXA in Intracerebral Hemorrhage
NCT07365150
recruitingphase_2
Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty（TKA）
NCT07127042
completedphase_4
Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section
NCT07013812
not_yet_recruitingphase_4
Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation
NCT06710327
unknownphase_3
Use of Transexamic Acid in Hip Replacement
NCT02587845
Clinical Trials (5)
Showing 5 of 5 trials
NCT07365150Not Applicable
Precision Use of TXA in Intracerebral Hemorrhage
NCT07127042Phase 2
Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty（TKA）
NCT07013812Phase 4
Tranexamic Acid to Reduce Blood Loss in Women Having Planned Cesarean Section
NCT06710327Phase 4
Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation
NCT02587845Phase 3
Use of Transexamic Acid in Hip Replacement
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5